Genmab A/S (GMAB)
32.95
+1.62
(+5.17%)
USD |
NASDAQ |
Jan 21, 16:00
32.96
+0.02
(+0.05%)
After-Hours: 20:00
Genmab Market Cap: 20.27B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 382.02B |
| Krystal Biotech, Inc. | 8.293B |
| Novo Nordisk A/S | 263.59B |
| Ascendis Pharma A/S | 13.24B |
| Evaxion AS | 26.40M |
Market Cap Related Metrics
| PE Ratio | 14.00 |
| PS Ratio | 5.769 |
| PEG Ratio | 0.1104 |
| Price to Book Value | 3.524 |
| Price to Free Cash Flow | 17.04 |
| Price | 32.95 |
| Earnings Yield | 7.15% |
| PEGY Ratio | 0.1104 |
| Operating PE Ratio | 15.66 |
| Normalized PE Ratio | 13.93 |